广受欢迎的防脱发药物与抑郁症及自杀存在关联

* *Key terms:* Finasteride (非那雄胺), prescribed (开处方/被处方), slow or reverse hair loss (减缓或逆转脱发), cosmetic appeal (美容吸引力/外观改善的吸引力), mental health consequences (心理健康后果), depression (抑郁), anxiety (焦虑), suicide (自杀). * *Draft:* 二十多年来，非那雄胺已被开处方给数百万寻求减缓或逆转脱发的男性。然而，在其美容吸引力背后，不断有证据表明其存在严重的心理健康后果，包括抑郁、焦虑，以及在某些情况下的自杀。 * *Refinement:* "Behind its cosmetic appeal" can be translated as "在其美容功效的背后" or "在其改善外观的吸引力背后". "Cosmetic appeal" implies the appeal of looking better. Let's go with "在其美容功效的背后" for a professional tone. * **Paragraph 2:** * *Source:* "Prof. Mayer Brezis of the Hebrew University of Jerusalem argues that both the medical community and regulators have repeatedly failed to protect the public by overlooking signs of psychiatric harm associated with the drug." * *Key terms:* Hebrew University of Jerusalem (耶路撒冷希伯来大学), medical community (医学界), regulators (监管机构), psychiatric harm (精神损害/精神伤害). * *Draft:* 耶路撒冷希伯来大学的Mayer Brezis教授认为，医学界和监管机构因忽视与该药相关的精神损害迹象，而屡次未能保护公众。 * *Refinement:* "Repeatedly failed" -> "屡次未能". "Overlooking" -> "忽视". The structure is solid. * **Paragraph 3:** * *Source:* "His review analyzed data from eight large studies published between 2017 and 2023. The findings show a clear trend: people who used finasteride were far more likely to experience mood disorders and suicidal thoughts than those who did not. This pattern appeared consistently across various national databases, including the FDA's adverse event system and healthcare records from Sweden, Canada, and Israel." * *Key terms:* Review (综述/评论), mood disorders (情绪障碍), suicidal thoughts (自杀念头), FDA's adverse event system (FDA不良事件报告系统), healthcare records (医疗记录). * *Draft:* 他的综述分析了2017年至2023年间发表的八项大型研究的数据。研究结果显示了一个明显的趋势：使用非那雄胺的人出现情绪障碍和自杀念头的可能性远高于未使用者。这种模式在各种国家数据库中一致出现，包括FDA的不良事件系统和来自瑞典、加拿大和以色列的医疗记录。 * *Refinement:* "Review" in academic context is usually "综述". "Far more likely" -> "可能性远高于". "Consistently" -> "一致出现". * **Paragraph 4:** * *Source:* "'The evidence is no longer anecdotal,' said Prof. Brezis, a professor emeritus of medicine and public health. 'We now see consistent patterns across diverse populations. And the consequences may have been tragic.'" * *Key terms:* Anecdotal (轶事性质的/个例的), professor emeritus (荣誉退休教授), diverse populations (不同人群). * *Draft:* “证据不再是轶事性质的，”医学与公共卫生荣誉退休教授Brezis说道。“我们现在看到了跨越不同人群的一致模式。其后果可能一直是悲剧性的。” * *Refinement:* "Anecdotal" in medical evidence context means "based on personal accounts rather than facts or research", often translated as "轶事证据" or simply "个例". "No longer anecdotal" -> "不再仅仅是轶事" or "不再是个例". Let's use "不再仅仅是轶事" to be precise. "Tragic" -> "悲剧性的". * **Paragraph 5:** * *Source:* "The report estimates that hundreds of thousands of users may have suffered from finasteride-related depression, and that hundreds -- possibly more -- may have died by suicide. Originally approved by the FDA in 1997 for male pattern baldness, the drug has remained popular for its perceived safety and effectiveness, particularly among younger men. Critics say, however, that its risks were downplayed or ignored." * *Key terms:* Male pattern baldness (男性型秃发/雄激素性脱发), perceived safety (被认为的安全性/公认的安全性), downplayed (淡化). * *Draft:* 该报告估计，数十万使用者可能遭受了与非那雄胺相关的抑郁，且有数百人——可能更多——可能死于自杀。该药最初于1997年获FDA批准用于治疗男性型秃发，因其被认为安全有效而一直保持流行，尤其是在年轻男性中。然而，批评人士称其风险被淡化或忽视了。 * *Refinement:* "Male pattern baldness" is technically "男性型脱发" or "雄激素性脱发". "Male pattern baldness" is commonly "男性型脱发". "Perceived safety" -> "被认为的安全性" or "公认的安全性". "Perceived" implies it might not actually be safe, so "被认为的安全性" is more accurate. * **Paragraph 6 (Heading):** * *Source:* "A Delayed Response, With a High Cost" * *Draft:* **迟来的回应，高昂的代价** * **Paragraph 7:** * *Source:* "Although the FDA recognized depression as a possible side effect in 2011 and added suicidal thoughts to the label in 2022, researchers had been warning of potential dangers as early as 2002. Internal FDA files from 2010, cited in Brezis' review, contained entire sections redacted as 'confidential,' including estimates of how many people might have been affected." * *Key terms:* Side effect (副作用), label (标签/说明书), redacted (编辑/删减/遮盖), confidential (机密). * *Draft:* 尽管FDA在2011年承认抑郁是一种可能的副作用，并于2022年将自杀念头加入药品标签，但研究人员早在2002年就已对潜在危险发出警告。Brezis的综述引用的FDA 2010年内部文件包含被标记为“机密”的大段删减内容，其中包括对可能受影响人数的估算。 * *Refinement:* "Redacted" usually means blacked out or removed for security/legal reasons. "被遮盖" or "被删减". "Entire sections redacted" -> "整段内容被标记为...而删减/遮盖". Let's use "整段内容因被标记为‘机密’而遭遮盖". Or simpler: "包含整段被标记为‘机密’而删减的内容". Let's stick to the meaning: the sections were redacted *as* confidential. * *Revised Draft:* Brezis的综述引用的FDA 2010年内部文件中，有整段内容因被标记为“机密”而被遮盖，其中包括对可能受影响人数的估算。 * **HTML Tag:** ` ` -> Keep as is or ignore? The prompt asks to translate the content. Usually, HTML tags are structural. I should probably keep the structure or just output the text. The prompt says "output the translation result". I will output the text paragraphs. If I need to keep the HTML structure, I will include it. Given the instruction "Retain all scientific data and technical details", keeping the HTML structure is safer to preserve the format of the original input. * *Decision:* I will retain the HTML tags to ensure the output format matches the input format. * **Paragraph 8:** * *Source:* "By 2011, only 18 suicides linked to finasteride had been reported to the FDA. Based on worldwide usage, Brezis concluded the actual number should have been in the thousands. 'It wasn't just underreporting,' Dr. Brezis wrote. 'It was a systemic failure of pharmacovigilance.'" * *Key terms:* Underreporting (漏报/报告不足), pharmacovigilance (药物警戒). * *Draft:* 截至2011年，向FDA报告的与非那雄胺相关的自杀案例仅有18例。基于全球使用情况，Brezis推断实际数字应以千计。“这不仅仅是漏报，”Brezis博士写道。“这是药物警戒的系统性失败。” * *Refinement:* "Pharmacovigilance" is a specific technical term "药物警戒". "System * *Draft:* 生物学原理很清楚。非那雄胺通过阻断睾酮转化为双氢睾酮（DHT）起作用，但这样做时，它也可能干扰像异孕烷醇酮这样的神经类固醇——这与大脑中的情绪调节有关。动物研究表明了对神经炎症的长期影响，甚至海马体结构的变化。 * *Refinement:* "Biological rationale" -> 生物学机理/原理. "Works by" -> 作用机制是. "Disrupt" -> 扰乱/干扰. "Neurosteroids" -> 神经类固醇. "Allopregnanolone" -> 异孕烷醇酮. "Hippocampal structure" -> 海马体结构. * *Polished:* 生物学机理十分明确。非那雄胺的作用机制是阻断睾酮转化为双氢睾酮（DHT），但在此过程中，它也可能干扰异孕烷醇酮等神经类固醇——这类物质与大脑的情绪调节有关。动物研究已显示出其对神经炎症的长期影响，甚至会导致海马体结构发生改变。 * **Segment 2:** `

For some patients, the consequences don't end when the pills do. Reports of lingering symptoms -- dubbed "post-finasteride syndrome" -- include insomnia, panic attacks, cognitive dysfunction, and suicidal thoughts that persist months or even years after stopping treatment.

` * *Draft:* 对一些病人来说，后果在停药后并没有结束。关于残留症状的报告——被称为“非那雄胺后综合征”——包括失眠、恐慌发作、认知功能障碍和自杀念头，这些在停止治疗后持续数月甚至数年。 * *Refinement:* "Consequences don't end when the pills do" -> 停药并不意味着后果终结. "Lingering symptoms" -> 挥之不去的症状/持续症状. "Dubbed" -> 被称为. "Panic attacks" -> 惊恐发作. "Cognitive dysfunction" -> 认知功能障碍. * *Polished:* 对部分患者而言，停药并不意味着后果的终结。有关挥之不去的症状报告——被称为“非那雄胺后综合征”——包括失眠、惊恐发作、认知功能障碍以及自杀念头，这些症状在停止治疗后仍持续数月甚至数年。 * **Segment 3:** `

Regulatory Gaps, Corporate Silence

` * *Draft:* 监管漏洞，企业沉默。 * *Refinement:* "Regulatory Gaps" -> 监管漏洞/监管缺失. "Corporate Silence" -> 企业的沉默. * *Polished:* **监管漏洞与企业的沉默** * **Segment 4:** `

The report is especially scathing toward the FDA and Merck. Despite having access to millions of patient records and robust pharmacovigilance tools, neither party acted in time, Brezis argues. The industry's silence was strategic, he suggests, driven by market pressures and legal liability -- echoing past controversies like Merck's handling of Vioxx.

` * *Draft:* 报告对FDA和默克公司特别严厉。Brezis认为，尽管拥有数百万患者记录和强大的药物警戒工具，双方都没有及时行动。他建议，行业的沉默是战略性的，由市场压力和法律责任驱动——呼应了过去的争议，如默克公司处理Vioxx的方式。 * *Refinement:* "Scathing" -> 严厉批评/措辞犀利. "Pharmacovigilance tools" -> 药物警戒工具. "Strategic" -> 战略性的/策略性的. "Vioxx" -> 万络（罗非昔布的商标名，通常翻译为万络）. * *Polished:* 该报告对FDA和默克公司（Merck）的批评尤为犀利。Brezis指出，尽管拥有数百万份患者记录和强大的药物警戒工具，但双方均未及时采取行动。他认为，业界的沉默是出于战略考量，受市场压力和法律责任驱使——这与默克公司当年处理万络（Vioxx）事件的争议如出一辙。 * **Segment 5:** `

"Nothing is more important to Organon than the safety of our medicines," the company recently claimed in a public statement. Yet none of the safety studies cited were initiated by the manufacturer.

` * *Draft:* “对欧加农来说，没有什么比我们药物的安全性更重要，”公司最近在公开声明中声称。然而，引用的安全研究没有一项是由制造商发起的。 * *Refinement:* "Organon" -> 欧加农（默沙东/默克旗下的子公司，此处保留通用译名欧加农）. "Initiated by" -> 由...发起/开展. * *Polished:* “对欧加农（Organon）而言，没有什么比我们药物的安全性更重要，”该公司最近在一份公开声明中宣称。然而，引用的各项安全性研究均非由制造商发起。 * **Segment 6:** `

The FDA, meanwhile, took five years to respond to a citizen petition calling for a black-box warning. Its final decision? To add suicidal ideation to the label -- but not as a formal warning.

` * *Draft:* 同时，FDA花了五年时间回应呼吁黑框警告的公民请愿。它的最终决定？将自杀意念添加到标签上——但不是作为正式警告。 * *Refinement:* "Citizen petition" -> 公民请愿. "Black-box warning" -> 黑框警告（最严重的药物警告形式）. "Suicidal ideation" -> 自杀意念. "Label" -> 药品标签/说明书. * *Polished:* 与此同时，FDA花了五年时间才回应一项呼吁添加黑框警告的公民请愿。其最终决定？将自杀意念列入药品标签——但并非作为正式警告。 * **Segment 7:** `

What Now?

` * *Draft:* 现在怎么办？ * *Polished:* **现状何如？** (Or simply **何去何从？** or **接下来怎么办？**) Let's go with **接下来怎么办？** or **现状与展望**. Given the context of recommendations, **何去何从** fits well, but **接下来怎么办？** is more direct. Let's use **何去何从？** for a slightly more formal tone suitable for an article subheading. Or simply **未来展望**. Let's stick to the meaning "What Now" -> **现状何如？** or **下一步措施？**. Let's use **何去何从？** as it captures the uncertainty and the need for direction. Actually, looking at the content, it's about recommendations. Let's use **何去何从？** * **Segment 8:** `

Brezis is calling for immediate changes in how drugs like finasteride are approved, monitored, and prescribed. His recommendations include suspending marketing of the drug for cosmetic purposes until safety is re-established, mandatory post-approval studies with strict enforcement, and systematic recording of drug histories in suicide investigations.

` * *Draft:* Brezis呼吁立即改变像非那雄胺这样的药物被批准、监测和开处方的方式。他的建议包括暂停该药物用于美容目的的营销，直到安全重新建立，强制执行批准后研究，以及在自杀调查中系统记录药物史。 * *Refinement:* "Approved, monitored, and prescribed" -> 审批、监测和处方. "Cosmetic purposes" -> 美容用途/ cosmetic purposes. "Mandatory post-approval studies" -> 强制性批准后研究/上市后研究. "Strict enforcement" -> 严格执行. "Systematic recording" -> 系统性记录. * *Polished:* Brezis呼吁立即改变非那雄胺等药物的审批、监测和处方方式。他的建议包括：在安全性得到重新确认前，暂停该药物用于美容用途的营销；强制开展且有严格执行机制的上市后研究；以及在自杀调查中系统性地记录用药史。 * **Segment 9:** `

"For many, those changes come too late. The paper is dedicated to one such individual -- a previously healthy man who took finasteride "just" to improve his hair. Within days, he spiraled into severe psychiatric distress. He never recovered. Months later, he took his own life."

` * *Draft:* “对许多人来说